Decamethonium bromide
CAS No. 541-22-0
Decamethonium bromide ( Decamethonium; Decamethonum; Syncurine; DECAMETHONIUM ION; Lopac-D-1260; (DM)Br2 )
Catalog No. M14934 CAS No. 541-22-0
Decamethonium Bromide is a nicotinic AChR partial agonist and neuromuscular blocking agent.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
500MG | 41 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDecamethonium bromide
-
NoteResearch use only, not for human use.
-
Brief DescriptionDecamethonium Bromide is a nicotinic AChR partial agonist and neuromuscular blocking agent.
-
DescriptionDecamethonium Bromide is a nicotinic AChR partial agonist and neuromuscular blocking agent.
-
SynonymsDecamethonium; Decamethonum; Syncurine; DECAMETHONIUM ION; Lopac-D-1260; (DM)Br2
-
PathwayEndocrinology/Hormones
-
TargetAChR
-
RecptorAChE; nAChR
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number541-22-0
-
Formula Weight418.29
-
Molecular FormulaC16H38Br2N2
-
Purity>98%(HPLC)
-
SolubilityEthanol: 25 mg/mL (59.76 mM); Water: 84 mg/mL (200.81 mM); DMSO: 34 mg/mL (81.28 mM)
-
SMILESC[N+](CCCCCCCCCC[N+](C)(C)C)(C)C.[Br-].[Br-]
-
Chemical Nametrimethyl-[10-(trimethylazaniumyl)decyl]azanium bromide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lee C, et al. Br J Anaesth, 2002, 88(5), 692-699.
molnova catalog
related products
-
Encenicline
Encenicline is a selective α7 nicotinic acetylcholine receptor?(nAChRs) agonist in development for treating cognitive impairment in schizophrenia and Alzheimer's disease.
-
Tolterodine tartrate
Tolterodine Tartrate(PNU-200583E; Kabi-2234) is a potent muscarinic receptor antagonists that show selectivity for the urinary bladder over salivary glands in vivo.
-
Edrophonium chloride
Edrophonium chloride is an acetylcholinesterase (AChE) inhibitor that is known to prevent the breakdown of the neurotransmitter acetylcholine by binding specifically to its catalytic site.